Related Experiment Video

Updated: Jun 9, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

Management of patients with coronary stents in the ICU

Emmanouil S Brilakis1, Subhash Banerjee

  • 1VA North Texas Healthcare System and University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75216, USA. esbrilakis@yahoo.com

Current Opinion in Critical Care
|August 26, 2010
PubMed

Insights

Patients with coronary stents in the ICU face risks like stent thrombosis. Optimal antiplatelet therapy and close monitoring are crucial for managing these cardiac patients and improving outcomes.

Area of Science:

  • Intensive Care Medicine
  • Cardiology
  • Interventional Cardiology

Background:

  • Patients with coronary stents admitted to the ICU are at higher risk for stent thrombosis.
  • Stent thrombosis is a serious complication associated with significant morbidity and mortality.

Purpose of the Study:

  • To review the current management strategies for ICU patients with coronary stents.
  • To highlight the risks and optimal therapeutic approaches for this patient population.

Main Methods:

  • Literature review of contemporary management practices.
  • Analysis of risks associated with coronary stents in the ICU setting.
  • Evaluation of antiplatelet therapy strategies.

Main Results:

  • Dual antiplatelet therapy (aspirin and P2Y12 inhibitor) is key to reducing stent thrombosis.
  • Discontinuation of antiplatelet therapy may be necessary due to bleeding or procedures, with aspirin continuation offering partial protection.
  • Short-acting antiplatelet agents like glycoprotein IIb/IIIa inhibitors can be used temporarily if all antiplatelet therapy is stopped.
  • Close patient monitoring facilitates early detection and treatment of cardiac complications.

Conclusions:

  • Optimizing outcomes for ICU patients with coronary stents requires awareness of risks.
  • Meticulous attention to antiplatelet therapy regimens is essential.
  • Close monitoring and prompt management are critical for improving patient outcomes.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...